Hearing Loss
488
57
68
286
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
105 trials with published results (22%)
Research Maturity
286 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.1%
20 terminated out of 488 trials
93.5%
+7.0% vs benchmark
1%
7 trials in Phase 3/4
37%
105 of 286 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 286 completed trials
Clinical Trials (488)
ACHIEVE Hearing Intervention Follow-Up Study
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Hearing and Brain Development Cohort in Children and Adolescents
SPI-1005 in Adults Receiving Cochlear Implant
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Maximizing Quality of Life After Cancer Through Rehabilitation
Perception of Speech in Context by Listeners With Healthy and Impaired Hearing
ACHIEVE Brain Health Follow-Up Study
Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment
Remote Microphone Performance Comparison in Adults With Hearing Loss
New Algorithms to Signal Processing for Speech Enhancement in Adult Cochlear Implant Recipients.
Comparing the Performance of a Categorical Loudness Scaling Based Fitting With a Behavioural Fitting in Adults With a Nucleus Cochlear Implant 3 Months Post-activation
Hearing Outcomes With the Nucleus® 8 Sound Processor and Nucleus® 7 Sound Processor in Adult Veteran and Non-veteran Cochlear Implant Recipients
Natural History of Autosomal Dominant Hearing Loss
Motivational Interviewing in Hearing Aid Users
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
Opto-electrical Cochlear Implants
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
Extra-cochlear Electrode Placement at the Post-auricular Vagus Nerve in Cochlear Implantation
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound